Literature DB >> 29169152

Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation.

Man Zou1, Yanhui Li2, Shu Xia1, Qian Chu1, Xiaoguang Xiao1, Hong Qiu1, Yu Chen1, Zu'an Zheng1, Fei Liu1, Liang Zhuang1, Shiying Yu1.   

Abstract

BACKGROUND/AIMS: Triple-negative breast cancer (TNBC) is a high-risk breast cancer phenotype without specific targeted therapy options and is significantly associated with increased local recurrence in patients treated with radiotherapy. CAVEOLIN-1 (CAV-1)-mediated epidermal growth factor receptor (EGFR) nuclear translocation following irradiation promotes DNA repair and thus induces radiation resistance. In this study, we aimed to determine whether knockdown of CAV-1 enhances the radiosensitivity of basal-like TNBC cell lines and to explore the possible mechanisms.
METHODS: Western blotting was used to compare protein expression in a panel of breast cancer cell lines. Nuclear accumulation of EGFR as well as DNA repair and damage at multiple time points following irradiation with or without CAV-1 siRNA pretreatment were investigated using western blotting and confocal microscopy. The radiosensitizing effect of CAV-1 siRNA was evaluated using a clonogenic assay. Flowcytometry was performed to analyse cell apoptosis and cell cycle alteration.
RESULTS: We found that CAV-1 is over-expressed in basal-like TNBC cell lines and barely expressed in HER-2-positive cells; additionally, we observed that HER-2-positive cell lines are more sensitive to irradiation than basal-like TNBC cells. Our findings revealed that radiation-induced EGFR nuclear translocation was impaired by knockdown of CAV-1. In parallel, radiation-induced elevation of DNA repair proteins was also hampered by pretreatment with CAV-1 siRNA before irradiation. Silencing of CAV-1 also promoted DNA damage 24 h after irradiation. Colony formation assays verified that cells could be radiosensitized after knockdown of CAV-1. Furthermore, G2/M cell cycle arrest and apoptosis enhancement may also contribute to the radiosensitizing effect of CAV-1 siRNA.
CONCLUSION: Our results support the hypothesis that CAV-1 knockdown by siRNA causes increased radiosensitivity in basal-like TNBC cells. The mechanisms associated with this effect are reduced DNA repair through delayed CAV-1-associated EGFR nuclear accumulation and induction of G2/M arrest and apoptosis through the combined effects of CAV-1 siRNA and radiation.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Basal-like triple negative breast cancer; Caveolin-1; DNA damage and repair; Radiosensitization; SiRNA

Mesh:

Substances:

Year:  2017        PMID: 29169152     DOI: 10.1159/000485291

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  6 in total

1.  Patient Derived Organoids Confirm That PI3K/AKT Signalling Is an Escape Pathway for Radioresistance and a Target for Therapy in Rectal Cancer.

Authors:  Kasun Wanigasooriya; Joao D Barros-Silva; Louise Tee; Mohammed E El-Asrag; Agata Stodolna; Oliver J Pickles; Joanne Stockton; Claire Bryer; Rachel Hoare; Celina M Whalley; Robert Tyler; Toritseju Sillo; Christopher Yau; Tariq Ismail; Andrew D Beggs
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

Review 2.  Modulating the Radiation Response for Improved Outcomes in Breast Cancer.

Authors:  Andrea M Pesch; Lori J Pierce; Corey W Speers
Journal:  JCO Precis Oncol       Date:  2021-01-25

3.  Caveolin-1 promotes radioresistance via IRGM-regulated autophagy in lung cancer.

Authors:  Xi Chen; Yuan-Liang Yan; Shuang-Shuang Zeng; Zhi-Cheng Gong; Zhi-Jie Xu
Journal:  Ann Transl Med       Date:  2021-01

Review 4.  Potential Mechanism Underlying the Role of Mitochondria in Breast Cancer Drug Resistance and Its Related Treatment Prospects.

Authors:  Yuefeng Li; Zhian Li
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

5.  Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells.

Authors:  Alessio Malacrida; Jacopo Erriquez; Maryamsadat Hashemi; Virginia Rodriguez-Menendez; Arianna Cassetti; Guido Cavaletti; Mariarosaria Miloso
Journal:  Biochem Biophys Rep       Date:  2022-09-27

6.  Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy.

Authors:  Jac A Nickoloff; Lynn Taylor; Neelam Sharma; Takamitsu A Kato
Journal:  Cancer Drug Resist       Date:  2021-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.